Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NAYA Biosciences, Inc. (IVF:NASDAQ), powered by AI.
NAYA Biosciences, Inc. is currently trading at $1.49. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for NAYA Biosciences, Inc. on Alpha Lenz.
NAYA Biosciences, Inc.'s P/E ratio is -0.0.
“NAYA Biosciences, Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -133.4%.”
Ask for details →INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
“NAYA Biosciences, Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -133.4%.”
Ask for details →NAYA Biosciences, Inc. (ticker: IVF) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 33 employees. Market cap is $3,843.
The current price is $1.49 with a P/E ratio of -0x and P/B of 0x.
ROE is -133.37% and operating margin is -116.56%. Annual revenue is $7M.